Ube Corporation · TSE:4208
Ube — Ube Industries — Q1 FY2017 Earnings Presentation
19 slides from Ube's earnings presentation, Aug 1, 2017
Slide 1: Financial Results for the 1st Quarter FY 2017
1 Financial Results for the 1st Quarter FY 2017 August 1, 2017
Slide 2: Scope of Consolidation
2 Scope of Consolidation - Financial Results for the 1st Quarter FY2017 - End of FY2016 End of FY2017 1Q Change Item Notes (A) (B) （B) - （A) Number of + UBE (Shanghai) LTD. consolidated 70 70 0 － Fukusei Tech Co.,Ltd subsidiaries Number of － UBE (Shanghai) LTD. equity method 25 23 -2 － Samekawa Read
Slide 3: Environmental Factors
3 Environmental Factors - Financial Results for the 1st Quarter FY2017 - FY2016 1Q FY2017 1Q Change Item (A) (B) (B) - (A) Exchange Rate Yen/$ 108.3 111.1 2.8 402 489 87 Naphtha CIF $/ｔ 32,600 39,700 7,100 Material Price Domestic Yen/KL Benzene(ACP) $/ｔ 635 787 152 Australian $/ｔ 68.1 97.0 28.9 Coal
Slide 4: Major P/L & B/S Items
4 Major P/L ＆ B/S Items - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Item (A) (B) (B) - (A) Net sales 138.0 159.6 21.5 Operating profit 1.6 9.0 7.4 Ordinary profit 0.8 10.1 9.3 Profit attributable to owners of parent 0.1 6.5 6.3 End of FY2016 End
Slide 5: Net Sales by Segment
5 Net Sales by Segment - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 3.1, Synthetic rubber 7.2, Chemicals 57.9 73.3 15.4 Battery Materials and Fine Chemicals 0.6, Polyimide and Special
Slide 6: Operating Profit by Segment
6 Operating Profit by Segment - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 3.8, Chemicals -2.3 6.1 8.4 Synthetic rubber 3.6, Polyimide and Specialty Products 1.0, etc Pharmaceutical 0
Slide 7: Analysis of Operating Profit
7 Analysis of Operating Profit - Financial Results for the 1st Quarter FY2017 - (Billions of yen) Operating income Variance Segment FY2016 1Q FY2017 1Q Difference Sales Fixed Price Others volume Cost (A) (B) (B) - (A) *1 *2 Chemicals -2.3 6.1 8.4 5.9 1.7 1.9 -1.0 Pharmaceutical 0.4 0.7 0.2 0.1 0.4 -
Slide 8: Non Operating Income/Expenses
8 Non Operating Income/Expenses - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Item (A) (B) (B) - (A) Operating profit 1.6 9.0 7.4 Net interest expenses 0.0 0.3 0.2 Share of profit of entities income/expenses 0.4 0.9 0.4 Non-operating accounted for
Slide 9: Extraordinary Income/Losses
9 Extraordinary Income/Losses - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Item (A) (B) (B) - (A) Loss on disposal of PP&E -0.3 -0.1 0.1 Others 0.0 0.0 0.0 Extraordinary income/losses -0.3 -0.1 0.2
Slide 10: Operating Profit - Net Income
10 Operating Profit - Net Income - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 1Q FY2017 1Q Difference Item (A) (B) (B) - (A) Operating profit 1.6 9.0 7.4 Non-operating income/expenses -0.7 1.0 1.8 Ordinary profit 0.8 10.1 9.3 Extraordinary income/losses -0.3 -0.1 0.2 Prof
Slide 11: Consolidated Balance Sheet
11 Consolidated Balance Sheet - Financial Results for the 1st Quarter FY2017 - (Billions of yen) End of FY2016 End of FY2017 1Q Difference Item (A) (B) (B) - (A) Current assets 295.0 296.4 1.3 Fixed assets 414.2 413.9 -0.2 Total assets 709.3 710.5 1.1 Interest-bearing debts 210.4 215.6 5.2 Other lia
Slide 12: Consolidated Statements of Cash Flows
12 Consolidated Statements of Cash Flows - Financial Results for the 1st Quarter FY2017 - (Billions of yen) Item FY2016 1Q FY2017 1Q Profit before income taxes 10.0, A.Cash flows from operating activities 17.0 19.0 Depreciation and amortization 8.5, etc. B.Cash flows from investing activities -6.8 -
Slide 13: Appendix
13 Appendix UBE
Slide 14: Reference: Progress of Major P/L Items
14 【Reference】 Progress of Major P/L Items - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2016 (A) FY2017 (B) Difference (B) - (A) 項 ⽬ 1Q 1Q 1Q （Progress） （Progress） 138.0 159.6 Net sales 616.5 700.0 83.5 21.5 (22.4%) (22.8%) 1.6 9.0 Operating profit 34.9 40.0 5.1 7.4 (4.7%) (22
Slide 15: Reference: FY2017 Changes in Results - Net Sales by Segment
15 【Reference】 FY2017 Changes in Results - Net Sales by Segment - (Billions of yen) FY2017 Full-year Progress Segment 1Q 2Q 3Q 4Q Total (forecast) % Chemicals 73.3 - - - 73.3 310.0 23.6% Pharmaceutical 2.4 - - - 2.4 10.0 24.0% Cement & Construction 57.2 - - - 57.2 230.0 24.9% Materials Machinery 16.
Slide 16: Reference: FY2017 Changes in Results - Operating Profit by Segment
16 【Reference】 FY2017 Changes in Results - Operating Profit by Segment - (Billions of yen) FY2017 Full-year Progress Segment 1Q 2Q 3Q 4Q Total (forecast) % Chemicals 6.1 - - - 6.1 18.0 33.9% Pharmaceutical 0.7 - - - 0.7 2.0 35.0% Cement & Construction 2.4 - - - 2.4 13.0 18.5% Materials Machinery 0.3
Slide 17: Reference: Consolidated Key Indicators
17 【Reference】 Consolidated Key Indicators - Financial Results for the 1st Quarter FY2017 - (Billions of yen) FY2017 full-year Item FY2016 1Q FY2017 1Q FY2016 full-year (forecast) Capital investment 9.0 5.9 42.0 44.0 Depreciation and amortization 8.3 8.5 35.0 34.4 R&D expenses 3.3 3.3 14.5 13.6 Adju
Slide 18: Reference: Major Subsidiaries
18 【Reference】 Major Subsidiaries - Financial Results for the 1st Quarter FY2017 - (Billions of yen) Operating Sales profit Subsidiaries and affiliates Business Change from FY2017 1Q FY2016 1Q UBE CHEMICALS (ASIA) PUBLIC CO., LTD Manufacture and sales of caprolactam and polyamide resin 9.7 ↑ Manufac
Slide 19: Forward-looking statements disclaimer
19 This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab